All News

Tracy Russell, senior director of State Government Affairs at CoverMyMeds, discusses how the role of the pharmacist in the specialty pharmacy space has expanded during the COVID-19 pandemic.

Data show that 89% of individuals treated for persistent AFiB remained symptom-free for up to 15 months after using the product.

Study shows that the vaccine candidate demonstrated superior neutralizing antibody titers over the control, Vaxzevria from AstraZeneca.

Clinical trial participants who took the drug lost up to 52 lb., or 24 kg, in the 72-week, phase 3 study.

Not only is burnout impacting pharmacists, but it also has unacceptable impacts on patients.

The APhA noted that burnout had been a problem in the pharmacy profession for a long time but had been exacerbated by the COVID-19 pandemic.

Patients want more out of community pharmacies in a post-pandemic culture.

Tizlelizumab is a unique anti-PD-1 monoclonal antibody that is being analyzed in 14 pivotal clinical trials across an array of solid tumors.

Omidubicel is a first-in-class, advanced nicotinamide-enabled stem cell therapy candidate being evaluated as the first potential allogeneic advanced cell therapy donor source for individuals with blood cancers in need of a transplant.

Educating patients can be especially rewarding with children.

FDA approves 15 mg upadacitinib (Rinvoq; AbbVie) for the treatment of adult patients with active ankylosing spondylitis who previously showed an inadequate response or intolerance to 1 or more tumor necrosis factor inhibitors.

Viloxazine extended-release capsules are indicated as a once-daily, flexible-dose nonstimulant drug for attention-deficit hyperactivity disorder.

Osteseconazole (Vivjoa) is the first FDA-approved treatment for recurrent vulvovaginal candidiasis, also known as chronic yeast infection, in women with a history of the condition who are not of reproductive potential.

Ertugliflozin (Steglatro) is a sodium glucose co-transporter 2 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Nonprescription migraine pain reliever combines acetaminophen, aspirin, and caffeine to relieve migraine pain.

Students from the University of the Sciences’ Philadelphia College of Pharmacy triumphed.

The advanced cell therapy is under development as an allogeneic hematopoietic stem cell transplant for patients with hematologic malignancies.

The company’s analysis shows data for the automated insulin delivery system for both T1D and T2D.

Most pharmacy schools don’t teach personal finance, so it’s up to you to set yourself up for success by taking control of your money while you’re still a student.

Nicole Palmer, senior manager of Volunteer Engagement at US Pharmacopeia (USP), and Michelle Then, PharmD, MBA, member of the USP Healthcare Safety and Quality Expert Committee, discuss the benefits of being a volunteer at USP and the opportunities for students and early career pharmacists.

Women in the study had higher rates of urgent procedures and were in poorer health when they received surgery.

Stay tuned at PharmacyTimes.com for exclusive session coverage and interviews with experts.

How would you handle these patients' questions?

Popular television shows and films have a lot more accurate representations of pharmacology than one may think.

An overview for community pharmacies of a process to minimize vaccine errors using a COVID-19 vaccine point of distribution as an example.

Mavacamten is a first-in-class, oral, allosteric modulator of cardiac myosin designed to decrease contractile function and improve VO2 in patients with obstructive hypertrophic cardiomyopathy.

Voxelotor (Oxbryta) is a hemoglobin S polymerization inhibitor indicated for the treatment of sickle cell disease in adults and pediatric patients 4 years of age and older.

Pharmacists’ performance and ultimately their own well-being on the job can be largely determined by their effectiveness in time management.

Data from the study shows a strong immune response in this age group following this dose, with no new safety signals.